Institutional Ownership Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT). We have compiled data on the 39 institutions that hold shares in the stock, with a total of 2.11 Million shares, which have been reported (via 13F filing form) to have a value of $13 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ronit Capital LLP
|
Nov 04, 2022 Q3 2022 |
562,547
shares
|
$3.48 Million
5.37% of portfolio
|
Q3 2022
Added 34.17%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
372,721
shares
|
$2.3 Million
0.0% of portfolio
|
Q1 2024
Reduced 3.91%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
298,800
shares
|
$1.85 Million
0.0% of portfolio
|
Q1 2024
Added 1.53%
|
|
|
Baldwin Brothers LLC
|
Apr 12, 2024 Q1 2024 |
154,130
shares
|
$952,523
0.1% of portfolio
|
Q1 2024
Added 8.51%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
134,528
shares
|
$831,383
0.0% of portfolio
|
Q1 2024
Added 2.18%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
129,379
shares
|
$799,562
0.0% of portfolio
|
Q1 2024
Added 9.38%
|
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
62,097
shares
|
$383,759
0.0% of portfolio
|
Q1 2024
Added 0.85%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
61,700
shares
|
$381,306
0.0% of portfolio
|
Q1 2024
Added 19.11%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2024 Q1 2024 |
50,068
shares
|
$309,420
0.0% of portfolio
|
Q1 2024
Added 101.78%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
41,191
shares
|
$254,560
0.0% of portfolio
|
Q1 2024
Added 79.76%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
39,501
shares
|
$244,116
0.0% of portfolio
|
Q1 2024
Added 16.14%
|
|
|
Gsa Capital Partners LLP
London, X0 |
May 03, 2024 Q1 2024 |
39,282
shares
|
$242,762
0.03% of portfolio
|
Q1 2024
Added 43.82%
|
|
|
Forbes J M & CO LLP
|
Apr 11, 2024 Q1 2024 |
34,000
shares
|
$210,120
0.03% of portfolio
|
Q3 2023
Reduced 49.25%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
19,920
shares
|
$123,105
0.0% of portfolio
|
Q3 2023
Added 10.7%
|
|
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
May 08, 2024 Q1 2024 |
19,170
shares
|
$118,470
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Blue Zone Wealth Advisors, LLC
|
Apr 17, 2024 Q1 2024 |
14,350
shares
|
$88,683
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
11,883
shares
|
$73,436
0.0% of portfolio
|
Q4 2023
Added 11.38%
|
|
|
Barclays PLC
London, X0 |
May 15, 2024 Q1 2024 |
10,293
shares
|
$63,610
0.0% of portfolio
|
Q1 2024
Added 0.38%
|
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
7,620
shares
|
$47,091
0.0% of portfolio
|
Q1 2024
Reduced 5.46%
|
|
|
Rhumbline Advisers
Boston, MA |
May 09, 2024 Q1 2024 |
7,502
shares
|
$46,362
0.0% of portfolio
|
Q1 2024
Added 3.15%
|
|
|
Strs Ohio
|
May 13, 2024 Q1 2024 |
5,800
shares
|
$35,844
0.0% of portfolio
|
Q1 2024
Reduced 6.45%
|
|
|
New York State Common Retirement Fund
|
May 07, 2024 Q1 2024 |
5,749
shares
|
$35,528
0.0% of portfolio
|
Q1 2024
Reduced 0.4%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
5,165
shares
|
$31,919
0.0% of portfolio
|
Q1 2024
Added 5.37%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
3,775
shares
|
$23,329
0.0% of portfolio
|
Q1 2024
Reduced 49.7%
|
|
|
American International Group, Inc.
New York, NY |
May 13, 2024 Q1 2024 |
3,664
shares
|
$22,643
0.0% of portfolio
|
Q1 2024
Reduced 0.84%
|
|